Ron Bentsur
Board Member
Nuvectis Pharma, Inc. (NVCT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-01-01–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Nuvectis Pharma, Inc. (NVCT) | Chairman & CEO | $653,987 | $2,588,526 |
| 2024 | Nuvectis Pharma, Inc. (NVCT) | President & Chief Executive Officer | $634,323 | $1,157,639 |
| 2023 | Nuvectis Pharma, Inc. (NVCT) | President & Chief Executive Officer | $615,250 | $2,690,725 |
| 2022 | Nuvectis Pharma, Inc. (NVCT) | President & Chief Executive Officer | $420,360 | $1,694,010 |
| 2021 | Nuvectis Pharma, Inc. (NVCT) | President, Chief Executive Officer and Director | — | $384,018 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.